Imaging and Spectral Analysis of the Crystalline Lens Using the "HYPERLAF" Slit Lamp
Key facts
- Who runs it
- Centre Hospitalier Universitaire de Saint Etienne
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 50 people, planned
- Started
- Oct 2026
- Expected to end
- 30 Dec 2026
- Type of study
- Interventional
- Treatments tested
- Non-contact observation of the crystalline lens nucleus
- Record updated
- 15 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Patients enrolled in or eligible for a social security program
- Age 18 or older
- Patients with cataracts. In cases of bilateral cataracts, both eyes will be photographed and analyzed
- Patient who has already received an instillation of 0.5% mydriaticum (tropicamide) and 10% neosynephrine (Théa Laboratories, Clermont-Ferrand, France) eye drops to dilate the pupil of the eye to be photographed (or both eyes)
- Signature of the consent form
Who cannot take part
- Poor or absent pupil dilation: patient with an allergy or intolerance to the eye drops used for pupil dilation; refusal of pupil dilation during the eye examination
- Severe blepharospasm making the examination impossible
- Pregnant or breastfeeding patient
- person under legal guardianship
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Cataract is the leading cause of reversible blindness and the first surgery worldwide. It corresponds to the crystalline lens opacification. Nevertheless, its grading remains mostly subjective and the Lens Opacities Classification System dating back 1993, is not used in daily practice and has not been revisited since. The HYPERLAF device developed by the start-up HYPEREYE is a modified slit lamp which combines imaging and spectral analysis, providing two quantitative objective scores: OPAK (opacity) and COLOR (spectral analysis). It is a non-CE marked prototype with non-invasive imaging methods.
The group in the trial
- Patients with cataractsTreatment being tested
Patients will be recruited from the ophthalmology clinic at Saint-Étienne University Hospital. After a clinical diagnosis of cataracts using a slit lamp, patients will be invited to participate in the clinical trial.
Treatment: Non-contact observation of the crystalline lens nucleus
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 15 October 2026